Young and Elderly Type 2 Diabetic Patients Inhaling Insulin with the AERx® Insulin Diabetes Management System: A Pharmacokinetic and Pharmacodynamic Comparison

Journal of Clinical Pharmacology

Volumn 43, Issue 11, 2003, Pages 1228-1234

  Henry, Robert R ^a   Mudaliar, Sunder ^a   Chu, Neelima ^a   Kim, Dennis ^a   Armstrong, Debra ^a   Davis, Trent T ^a   An, Bob ^b   Reinhardt, Rickey R ^b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b NOVO NORDISK INC   (United States)

Author keywords

AERx Insulin Diabetes Management System; Pharmacodynamics; Pharmacokinetics; Pulmonary insulin delivery; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; ELDERLY CARE; FEMALE; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HYPOGLYCEMIA; INHALATIONAL DRUG ADMINISTRATION; INSULIN TREATMENT; LONG TERM CARE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLISM; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; SIDE EFFECT; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED;

EID: 0142040183     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270003258657     Document Type: Article

References (24)

1. Heinemann L, Pfutzner A, Heise T: Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery. Curr Pharm Des 2001;7(14):1327-1351.
2. Schuster J, Rubsamen R, Lloyd P, Lloyd J: The AERx aerosol delivery system. Pharm Res 1997;14(3):354-357.
3. Gonda I, Schuster JA, Rubsamen RM, Lloyd P, Cipolla D, Farr SJ: Inhalation delivery systems with compliance and disease management capabilities. J Control Release 1998;53(1-3):269-274.
4. Cipolla DC, Farr SJ, Gonda I, Herst CV, Lee RY, Lloyd P, et al: Design and testing of aerosol delivery systems for reproducible clinical performance. J Aerosol Med Deposition Clear Eff Lung 1998;11:S84-S88.
5. Farr SJ, McElduff A, Mather LE, Okikawa J, Ward ME, Gonda I, et al: Pulmonary insulin administration using the AERx (TM) system: physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects. Diabetes Technol Ther 2000;2(2):185-197.
6. Chan HK, Daviskas E, Eberl S, Robinson M, Bautovich G, Young I: Deposition of aqueous aerosol of technetium-99m diethylene triamine penta-acetic acid generated and delivered by a novel system (AERx) in healthy subjects. Eur J Nucl Med 1999;26(4):320-327.
7. Brunner GA, Balent B, Ellmerer M, Schaupp L, Siebenhofer A, Jendle JH, et al: Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients 1. Diabetologia 2001;44(3):305-308.
8. Himmelmann A, Jendle J, Mellen A, Petersen AH, Dahl UL, Wollmer P: The impact of smoking on inhaled insulin. Diabetes Care 2003;26(3):677-682.
9. Henry RR, Mudaliar SR, Howland WC III, Chu N, Kim D, An B, et al: Inhaled insulin using the AERx insulin diabetes management system in healthy and asthmatic subjects. Diabetes Care 2003;26(3):764-769.
10. Adamson U, Ronnemaa T, Petersen AH, Hermansen K: Inhaled human insulin via the AERx®) insulin diabetes management system in combination with NPH insulin offers the same metabolic control as intensive s.c. therapy: a proof of concept trial in type 2 diabetic patients. Diabetologia 2002;45(Suppl. 2):A.
11. Cefalu WT, Skyler JS, Kourides IA, Landschulz WH, Balagtas CC, Cheng S, et al: Inhaled human insulin treatment in patients with type 2 diabetes mellitus. Ann Intern Med 2001;134(3):203-207.
12. Skyler JS, Cefalu WT, Kourides IA, Landschulz WH, Balagtas CC, Cheng SL, et al: Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study. Lancet 2001;357(9253):331-335.
13. Lipson LG: Diabetes in the elderly: diagnosis, pathogenesis, and therapy. Am J Med 1986;80(5A):10-21.
14. Rosenstock J: Management of type 2 diabetes mellitus in the elderly: special considerations. Drugs Aging 2001;18(1):31-44.
15. Chow SC, Tse SK: A related problem in bioavailability-bioequivalence studies estimation of the intrasubject variability with a common Cv. Biom J 1990;32(5):597-607.
16. Heinemann L, Weyer C, Rauhaus M, Heinrichs S, Heise T: Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart. Diabetes Care 1998;21(11):1910-1914.
17. , Fuso L, Cotroneo P, Basso S, De Rosa M, Manto A, Ghirlanda G, et al: Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus. Chest 1996;110(4):1009-1013.
18. Sandler M, Bunn AE, Stewart RI: Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 1987;135(1):223-229.
19. Mori H, Okubo M, Okamura M, Yamane K, Kado S, Egusa G, et al: Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus. Intern Med 1992;31(2):189-193.
20. Balent B, Brunner GA, Sendlhofer G, Ellmerer M, Schaupp L, Brandmair H, et al: Dose-response and system efficiency of pulmonary insulin in subjects with type 1 diabetes. Diabetologia 2000;43(Suppl. 1):A202.
21. Perera AD, Kapitza C, Nosek L, Fishman RS, Shapiro DA, Heise T, et al: Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the aerodose insulin inhaler in patients with type 2 diabetes. Diabetes Care 2002;25(12):2276-2281.
22. Barbieri M, Rizzo MR, Manzella D, Paolisso G: Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians. Diabetes-Metab Res Rev 2001;17(1):19-26.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412-419.
24. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237(3):E214-E223.